Gold bars to be exempt from tariffs, White House clarifies
DUBLIN - Investment firm BlackRock (NYSE:BLK), Inc. has disclosed a 1.64% ownership position in Mural Oncology plc, according to a regulatory filing published Tuesday.
The disclosure, made in compliance with the Irish Takeover Panel Act requirements, reveals BlackRock holds 283,428 shares in the oncology company. This position includes 283,413 owned or controlled relevant securities and 15 shares through cash-settled derivatives.
The filing indicates BlackRock returned 3,600 shares on loan as part of its recent dealings in Mural Oncology securities. The position was reported as of June 9, 2025.
The disclosure was made under Rule 8.3 of the Irish Takeover Panel Act, which requires persons with interests in relevant securities representing 1% or more to report their holdings.
BlackRock reported no short positions in Mural Oncology securities, according to the filing.
The Form 8.3 disclosure, which serves as an opening position disclosure, is standard procedure when companies become subject to takeover rules. The filing does not indicate any active takeover offer for Mural Oncology at this time.
The disclosure was submitted to the Regulatory Information Service as required by Irish takeover regulations.
This article is based on information contained in a regulatory press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.